As the non-invasive neurotech sector continues to evolve, it will be fascinating to see how different companies balance the need for rapid innovation with the requirements of medical rigor and regulatory compliance. The success of pioneers like Neurovalens could pave the way for a new generation of medical devices that bridge the gap between consumer tech and traditional medical treatments.